Argon plasma coagulation ablation of Barrett's oesophagus

References

• Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510–3.
   Google Scholar
• Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287–9.
   Google Scholar
• Bremner CG, Lynch VP, Ellis FH, Jr. Barrett’s esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970;68:209–16.
   PubMed Web of Science ®Google Scholar
• Falk GW. Gastroesophageal reflux disease and Barrett’s esophagus. Endoscopy 2001;33:109–18.
   PubMedGoogle Scholar
• Williamson WA, Ellis FH, Jr, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, et al. Barrett’s esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151: 2212–6.
   PubMedGoogle Scholar
• Dresner SM, Griffin SM, Wayman J, Bennett MK, Hayes N, Raimes SA. Human model of duodenogastro-oesophageal reflux in the development of Barrett’s metaplasia. Br J Surg 2003;90:1120–8.
   PubMedGoogle Scholar
• Barrett NR. Chronic peptic ulcer of the oesophagus and “oesophagitis”. Br J Surg 1950;38:175–82.
   PubMed Web of Science ®Google Scholar
• Allison PR, Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax 1953;8:87–101.
   PubMed Web of Science ®Google Scholar
• Menke-Pluymers MB, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett’s oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut 1994; 1348–51.
   Google Scholar
• Altorki NK, Sunagawa M, Little AG, Skinner DB. Highgrade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97–9, 99–100 [discussion].
   Google Scholar
• Heitmiller RF, Redmond M, Hamilton SR. Barrett’s esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66 71.
   Google Scholar
• Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol 1993;88:1832–6.
   PubMed Web of Science ®Google Scholar
• Nigro JJ, Hagen JA, DeMeester TR, DeMeester SR, Theisen J, Peters JH, et al. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999;230:433–8, 438–40 [discussion].
   Google Scholar
• Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett’s esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992;54:199–204.
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 2000;119:333 8.
   Google Scholar
• Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett’s metaplasia has regional variations in the west. Gastroenterology 2002;122:588–90.
   Google Scholar
• Ackroyd R, Wakefield SE, Williams JL, Stoddard CJ, Reed MW. Surveillance of Barrett’s esophagus: a need for guidelines? Dis Esophagus 1997;10:185–9.
   PubMedGoogle Scholar
• Mandal A, Playford RJ, Wicks AC. Current practice in surveillance strategy for patients with Barrett’s oesophagus in the UK. Aliment Pharmacol Ther 2003;17:1319–24.
   Google Scholar
• Cooper BT, Neumann CS, Cox MA, Iqbal TH. Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett’s oesophagus. Aliment Pharmacol Ther 1998;12: 893–7.
   PubMedGoogle Scholar
• Sessler MJ, Becker HD, Flesch I, Grund KE. Therapeutic effect of argon plasma coagulation on small malignant gastrointestinal tumors. J Cancer Res Clin Oncol 1995;121:235–8.
   PubMedGoogle Scholar
• Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW. Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J Clin Pathol 1999;52: 509–12.
   Google Scholar
• Watson JP, Bennett MK, Griffin SM, Matthewson K. The tissue effect of argon plasma coagulation on esophageal and gastric mucosa. Gastrointest Endosc 2000;52:342–5.
   PubMed Web of Science ®Google Scholar
• Dumoulin FL, Terjung B, Neubrand M, Scheurlen C, Fischer HP, Sauerbruch T. Treatment of Barrett’s esophagus by endoscopic argon plasma coagulation. Endoscopy 1997; 29:751–3.
   PubMedGoogle Scholar
• Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett’s esophagus by argon beam plasma coagulation. Am J Gastroenterol 1998;93: 1810–5.
   Google Scholar
• Van Laethem JL, Cremer M, Peny MO, Delhaye M, Deviere J. Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 1998;43:747–51.
   Google Scholar
• Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, et al. High power setting argon plasma coagulation for the eradication of Barrett’s esophagus. Am J Gastroenterol 2000;95:1661 8.
   Google Scholar
• Schulz H, Miehlke S, Antos D, Schentke KU, Vieth M, Stolte M, et al. Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with highdose omeprazole. Gastrointest Endosc 2000;51:659–63.
   PubMed Web of Science ®Google Scholar
• Basu KK, Pick B, Bale R, West KP, de Caestecker JS. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium. Gut 2002;51:776–80.
   Google Scholar
• Kahaleh M, Van Laethem JL, Nagy N, Cremer M, Deviere J. Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 2002;34:950–5.
   PubMed Web of Science ®Google Scholar
• Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus. Clin Gastroenterol Hepatol 2003;1:258–63.
   Google Scholar
• Tigges H, Fuchs KH, Maroske J, Fein M, Freys SM, Muller J, et al. Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett’s esophagus. J Gastrointest Surg 2001;5:251 9.
   Google Scholar
• Pagani M, Granelli P, Chella B, Antoniazzi L, Bonavina L, Peracchia A. Barrett’s esophagus: combined treatment using argon plasma coagulation and laparoscopic antireflux surgery. Dis Esophagus 2003;16:279–83.
   PubMed Web of Science ®Google Scholar
• Morino M, Rebecchi F, Giaccone C, Taraglio S, Sidoli L, Ferraris R. Endoscopic ablation of Barrett’s esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication. Surg Endosc 2003;17:539–42.
   PubMedGoogle Scholar
• Ackroyd R, Tam W, Schoeman M, Devitt PG, Watson DI. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett’s esophagus after antireflux surgery. Gastrointest Endosc 2004;59:1–7.
   Google Scholar
• Hage M, Siersema PD, van Dekken H, Steyerberg EW, Haringsma J, van de Vrie W, et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial. Gut 2004;53: 785–90.
   Google Scholar
• Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MWR. Endoscopic ablation of Barrett’s oesophagus: a randomised controlled trial of photodynamic therapy (PDT) versus argon plasma coagulation (APC). Gut 2004; Suppl III:A55–209.
   Google Scholar
• Van Laethem JL, Peny MO, Salmon I, Cremer M, Deviere J. Intramucosal adenocarcinoma arising under squamous reepithelialisation of Barrett’s oesophagus. Gut 2000;46:574–7.
   Google Scholar
• Shand A, Dallal H, Palmer K, Ghosh S, MacIntyre M. Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation. Gut 2001;48:580–1.
   Google Scholar
• Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett’s oesophagus. Med J Aust 2004;180:387–91.
   Google Scholar
• Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg- Knol EC, Lamers CB, et al. Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study. Gut 1999;45:489–94.
   Google Scholar
• Fass R, Sampliner RE, Malagon IB, Hayden CW, Camargo L, Wendel CS, et al. Failure of oesophageal acid control in candidates for Barrett’s oesophagus reversal on a very high dose of proton pump inhibitor. Aliment Pharmacol Ther 2000;14:597–602.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett’s esophagus. An overrated risk? Gastroenterology 1984;927–33.
   Google Scholar
• Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 1985;313:857–9.
   Google Scholar
• Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett’s oesophagus. Br J Surg 1988;75:760–3.
   Google Scholar
• Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett’s esophagus. In: Am J Gastroenterol 1988;83:291–4.
   PubMed Web of Science ®Google Scholar
• Savary M, Ollyo JB, Monnier P. Frequency and importance of endobrachyesophagus in reflux disease. In: Siewert JR, Holscher AH, editors. Diseases of the esophagus. New York, NY: Springer-Verlag; 1984. pp 529–36.
   Google Scholar
• Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;1249–56.
   Google Scholar
• Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M. Adenocarcinoma in Barrett’s oesophagus: an overrated risk. Gut 1989;30:14–8.
   PubMedGoogle Scholar
• Ovaska J, Miettinen M, Kivilaakso E. Adenocarcinoma arising in Barrett’s esophagus. Dig Dis Sci 1989;34:1336–9.
   Google Scholar
• McCallum RW, Polepalle SC, Davenport K. Progress report on ACG Barrett’s Esophagus Study. Am J Gastroenterol 1990;85:A5.1.
   PubMedGoogle Scholar
• Williamson WA, Ellis FH, Jr, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, et al. Barrett’s esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151: 2212–6.
   PubMedGoogle Scholar
• Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus. Gut 1991;32:1441–6.
   Google Scholar
• Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M. Length of Barrett’s oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155–8.
   Google Scholar
• Bonelli L. Barrett’s esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee). Endoscopy 1993;25:652–4.
   Google Scholar
• Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92: 212–5.
   Google Scholar
• O’Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett’s esophagus: report on the Cleveland Clinic Barrett’s Esophagus Registry. Am J Gastroenterol 1999;94:2037–42.
   Google Scholar
• Mork H, Barth T, Kreipe HH, Kraus M, Al-Taie O, Jakob F, et al. Reconstitution of squamous epithelium in Barrett’s oesophagus with endoscopic argon plasma coagulation: a prospective study. Scand J Gastroenterol 1998;33: 1130–4.
   Google Scholar
• Grade AJ, Shah IA, Medlin SM, Ramirez FC. The efficacy and safety of argon plasma coagulation therapy in Barrett’s esophagus. Gastrointest Endosc 1999;50:18–22.
   PubMedGoogle Scholar
• Van Laethem JL, Jagodzinski R, Peny MO, Cremer M, Deviere J. Argon plasma coagulation in the treatment of Barrett’s high-grade dysplasia and in situ adenocarcinoma. Endoscopy 2001;33:257–61.
   Google Scholar
• Morris CD, Byrne JP, Armstrong GR, Attwood SE. Prevention of the neoplastic progression of Barrett’s oesophagus by endoscopic argon beam plasma ablation. Br J Surg 2001; 88:1357–62.
   PubMed Web of Science ®Google Scholar
• Kelty CJ, Ackroyd R, Brown NJ, Brown SB, Reed MW. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett’s esophagus. Surg Endosc 2004;18: 452–8.
   Google Scholar